Satellos Bioscience Inc T.MSCL

Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Post by Drambueyon Apr 24, 2024 3:10pm

89 Views

Post# 36005655

Post deleted SNOWFLAKES MANAGEMENT

So you deleted my post did it hit too close to home SNOWFLAKE MANAGEMENT? Let me get this straight you roll back the stock 20 to one collect $1.4 million in salaries and the stock is trading at $0.02 precondition ALL FACTS. So you run to mommy because in this new world how dare you be held accountable for the pathetic job that your management team is doing, but hey who cares you all are still collecting money?

<< Previous

Bullboard Posts

Red Light Holland and Costco Canada partner on mushroom kits